Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy
Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy
Not yet recruiting · NCT07192848 · Registry updated 2025-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Not yet recruiting | Phase 2 | 2025-09-25 | NCT07192848 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Song Peng | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | Shenzhen | China | 1 |